基于因子分析法的我国医药流通行业部分上市公司绩效分析  

Performance Analysis of Some Listed Companies in China’s Pharmaceutical Circulation Industry Based on Factor Analysis Method

作　　者：葛夫莲 徐文[1] GE Fulian;XU Wen(Shandong University of Traditional Chinese Medicine,Jinan,Shandong,China 250355)

机构地区：[1]山东中医药大学

出　　处：《中国药业》2019年第19期6-9,共4页China Pharmaceuticals

基　　金：山东省中医药科技发展计划项目[2017-036]

摘　　要：目的分析医药流通行业存在的问题并提出建议,为行业发展提供参考。方法以我国医药流通行业20家沪、深两市上市公司2017年财务数据为研究对象,选取11项财务指标(X1至X11),运用因子分析法对其进行绩效分析。结果发展能力对医药流通行业上市公司绩效的影响最大,盈利能力次之,营运能力和偿债能力影响较小。结论尽管医药流通行业处于快速发展时期,但行业发展不均衡,要提高绩效水平,需在保持核心能力不断提高的基础上注重各项能力的平衡发展,以及行业内部的协调发展。Objective To analyze the problems existing in the pharmaceutical circulation industry and put forward some suggestions,and to provide reference for the development of this industry.Methods The financial data of 20 companies in China’s pharmaceutical circulation industry listed in Shanghai and Shenzhen in 2017 were taken as the research objects.Totally 11 financial indicators(X1 to X11)were selected and their performance was analyzed by factor analysis method.Results The development ability had the greatest impact on the performance of listed companies in the pharmaceutical circulation industry,followed by profitability,while the operational ability and debt paying ability had little impact on performance.Conclusion Although the pharmaceutical circulation industry is in a period of rapid development,the development of the industry is uneven.To improve the performance level,it is necessary to pay attention to the balanced development of each ability and the coordinated development within the industry based on keeping the continuous improvement of core competence.

关 键 词：因子分析法 医药流通 上市公司 绩效分析 

分 类 号：R95[医药卫生—药学]